Emergent BioSolutions
EBS
#8058
Rank
โ‚ฌ0.32 B
Marketcap
6,26ย โ‚ฌ
Share price
-0.55%
Change (1 day)
21.87%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): โ‚ฌ50.68 Million

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚ฌ0.64 Billion. In 2025 the company made an earning of โ‚ฌ0.12 Billion, an increase over its 2024 earnings that were of -โ‚ฌ62.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ50.68 M-58.85%
2025 โ‚ฌ0.12 B-297.64%
2024 -โ‚ฌ62.33 Million-88.82%
2023 -โ‚ฌ0.56 Billion242.73%
2022 -โ‚ฌ0.17 Billion-153.8%
2021 โ‚ฌ0.30 B-20.43%
2020 โ‚ฌ0.38 B278.02%
2019 โ‚ฌ0.10 B27.11%
2018 โ‚ฌ79.1 M-27.12%
2017 โ‚ฌ0.10 B17.21%
2016 โ‚ฌ92.6 M0.45%
2015 โ‚ฌ92.19 M73.51%
2014 โ‚ฌ53.13 M41.36%
2013 โ‚ฌ37.59 M35.2%
2012 โ‚ฌ27.8 M0.4%
2011 โ‚ฌ27.69 M-56.46%
2010 โ‚ฌ63.59 M76.73%
2009 โ‚ฌ35.98 M32.94%
2008 โ‚ฌ27.07 M-5.62%
2007 โ‚ฌ28.68 M
2005 โ‚ฌ41.53 M269.89%
2004 โ‚ฌ11.22 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.18 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.40 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ8.67 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚ฌ10.15 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚ฌ17.88 M-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.27 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.96 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel